12,102 followers
RT @FrontOncology: New research: The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a…
RT @FrontOncology: New research: The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a…
New research: The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a nationwide real world comparative retrospective cohort study: Introduction Palbociclib and ribociclib are indicated in the… https://t.